Elixinol Global Limited Annual Report 2020

In the directors’ opinion: – the attached financial statements and notes comply with the Corporations Act 2001 , the Accounting Standards, the Corporations Regulations 2001 and other mandatory professional reporting requirements – the attached financial statements and notes comply with International Financial Reporting Standards as issued by the International Accounting Standards Board as described in Note 2 to the financial statements; – the attached financial statements and notes give a true and fair view of the Group’s financial position as at 31 December 2020 and of its performance for the financial year ended on that date; – there are reasonable grounds to believe that the Company will be able to pay its debts as and when they become due and payable; and – at the date of this declaration, there are reasonable grounds to believe that the members of the Extended Closed Group will be able to meet any obligations or liabilities to which they are, or may become, subject by virtue of the deed of cross guarantee described in Note 35 to the financial statements. The directors have been given the declarations required by section 295A of the Corporations Act 2001 . Signed in accordance with a resolution of directors made pursuant to section 295(5)(a) of the Corporations Act 2001 . On behalf of the directors Oliver Horn Global Chief Executive Ocer and Executive Director 25 February 2021 Sydney Directors’ Declaration 31 December 2020 F INANCI AL REPORT Company Overview Financial Report Shareholder Information FY2020 Milestones 93 Strategy and Market Update